Invitation to presentation of Bactiguard’s interim report for the second quarter on August 15

Bactiguard Holding AB publishes the interim report for the second quarter 2014
on August 15 at 08:00 CET.
In connection with this, a telephone conference for analysts and media will be
held at 10:00 CET on August 15. CEO Johan Rugfelt and CFO Fredrik Järrsten will
present the interim report and answer questions.

The report will be available at www.bactiguard.com from 08:00 CET the same day.

To participate in the conference, please dial +46 851999354

For further information, please contact:

Cecilia Edström, Director of Communications
Mobile: +46 722 262 328; e-mail: cecilia.edstrom@bactiguard.com

For questions related to participation in the conference call, please contact:
Sarah Bardling
Tfn: +46 8 440 58 69; e-mail: sarah.bardling@bactiguard.com
Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare
associated infections, reducing the use of antibiotics and saving lives by
developing and supplying infection prevention solutions to the healthcare
industry. The company’s patented coating prevents healthcare associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of coated
catheters for the urinary and respiratory tract and the blood stream. Bactiguard
is currently in a strong expansion phase, focused on new markets in the EU,
Middle East, Asia and South America. The company reported  sales of
approximately SEK 130 million in 2013, has 60 employees, headquarters in
Stockholm and production facilities in Markaryd and Malaysia. More information
is available at www.bactiguard.se